Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:560-567
Published online before print August 3, 2009, doi: 10.1161/CIRCULATIONAHA.109.877092
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: August 18, 2009, Volume 120, Number 7
Right arrow All Versions of this Article:
120/7/560    most recent
CIRCULATIONAHA.109.877092v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brilakis, E. S.
Right arrow Articles by Bhatt, D. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brilakis, E. S.
Right arrow Articles by Bhatt, D. L.
Related Collections
Right arrow Compliance/Adherence
Right arrow Risk Factors
Right arrow Acute coronary syndromes
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2009;120:560-567.)
© 2009 American Heart Association, Inc.


Coronary Heart Disease

Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease

Results From the Get With the Guidelines Program

Emmanouil S. Brilakis, MD, PhD; Adrian F. Hernandez, MD, MHS; David Dai, MS; Eric D. Peterson, MD, MPH; Subhash Banerjee, MD; Gregg C. Fonarow, MD; Christopher P. Cannon, MD; Deepak L. Bhatt, MD, MPH

From the VA North Texas Healthcare System and University of Texas Southwestern Medical Center (E.S.B., S.B.), both in Dallas, Tex; Duke Clinical Research Institute and Duke University Medical Center (A.F.H, D.D., E.D.P.), Durham, NC; UCLA Medical Center (G.C.F.), Los Angeles, Calif; TIMI Group and Harvard University (C.P.C.), Boston Mass; and VA Boston Healthcare System and Brigham and Women’s Hospital (D.L.B), Boston, Mass.

Correspondence to Emmanouil S. Brilakis, MD, PhD, Dallas VA Medical Center (111A), 4500 S Lancaster Rd, Dallas, TX 75216. E-mail esbrilakis{at}yahoo.com

Received January 11, 2009; accepted June 8, 2009.

Background— Patients with prior atherosclerosis in 1 or more vascular territories (coronary, cerebrovascular, or peripheral arterial) who present with acute coronary syndromes have high cardiovascular risk and may benefit significantly from evidence-based therapies, yet whether these are used consistently is unknown.

Methods and Results— The Get With the Guidelines–Coronary Artery Disease database was queried to determine whether compliance with quality-of-care treatments for acute coronary syndrome patients was associated with the extent of prior vascular disease. A total of 143 999 patients enrolled at 438 sites between January 2000 and January 2008 were classified according to the absence (n=98 136; 68%) or presence of known preexistent atherosclerosis (before admission) in 1, 2, or 3 vascular territories (n=37 633 [26%], n=7369 [5%], and n=861 [0.6%], respectively). Overall in-hospital mortality was 5.3%, and mean length of stay was 5.6±6.7 days. Compared with patients without prior vascular disease, patients with prior vascular disease were older and had more comorbidities. They were less likely to undergo coronary revascularization and had longer duration of hospital stay and higher in-hospital mortality. After adjustment for clinical and hospital characteristics, compared with patients without prior vascular disease, patients with prior vascular disease had higher mortality and were less likely to receive 3 particular treatments (lipid-lowering therapy, smoking cessation counseling, and angiotensin-converting enzyme inhibitor for left ventricular dysfunction).

Conclusions— Compared with acute coronary syndrome patients without prior vascular disease, those with prior atherosclerosis had higher in-hospital mortality yet were paradoxically less likely to receive specific evidence-based acute coronary syndrome treatments, which can form the basis for targeted intervention.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 543-545. [Extract] [Full Text]